Renal Cancer

Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States. December 23, 2024

Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial. December 23, 2024

Non-clear cell renal cell carcinoma narrative review: where we are in 2024. December 20, 2024

Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT's performance in educating patients and trainees. December 20, 2024

Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review. December 20, 2024

Stereotactic ablative radiotherapy for primary kidney cancer - An international patterns of practice survey. December 19, 2024

Renal cell carcinoma and macrophage research: A bibliometric analysis (2004-2023). December 19, 2024

The Current State of the Diagnoses and Treatments for Clear Cell Renal Cell Carcinoma. December 18, 2024

High Expression of MRPL23 Is Associated with Poor Survival in Clear-Cell Renal Cell Carcinoma. December 18, 2024

The Impact of Socioeconomic Factors on Kidney Transplantation: A Systematic Review of Low- and Middle-Income Countries December 17, 2024

Challenges in the Diagnosis and Management of Renal Cell Carcinoma With Sarcomatoid Differentiation: A Case Report. December 17, 2024

Biomarker analyses from the phase 3 randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma. December 17, 2024

Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis of Individual Patient Data. December 16, 2024

Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review. December 16, 2024

Defining a threshold for safe surgical management of vena cava thrombus in renal cell carcinoma patients: evidence from German total population data with 3,700 cases from 2006 to 2020. December 13, 2024

Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy. December 13, 2024

Exploring the effect of patient characteristics on the association between warm ischemia time and the risk of postoperative acute kidney injury after partial nephrectomy. December 12, 2024

Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP). December 12, 2024

Computed Tomography Measures of Perinephric Adipose Tissue and C-Reactive Protein-to-Albumin Ratio are Associated with Common Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma Patients. December 11, 2024

Cost-Effectiveness Analysis of Lenvatinib plus Pembrolizumab or Everolimus as First-Line Treatment for Advanced Renal Cell Carcinoma. December 11, 2024

Page 1 of 456